Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03433183 |
| Title | SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Sarcoma Alliance for Research through Collaboration |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Children's National Medical Center | Washington | District of Columbia | 20010 | United States | Details | |
| Johns Hopkins University | Baltimore | Maryland | 21287 | United States | Details | |
| National Cancer Institute | Bethesda | Maryland | 20892 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Washington University | Saint Louis | Missouri | 63110 | United States | Details |